High ratio of triglycerides to HDL-cholesterol predicts extensive coronary disease

Clinics

Volumn 63, Issue 4, 2008, Pages 427-432

  Da Luz, Protasio Lemos ^a   Favarato, Desiderio ^a   Faria Neto Jr , Jose Rocha ^b   Lemos, Pedro ^a   Chagas, Antonio Carlos Palandri ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

Cholesterol; Coronary disease; HDL; Lipids; Triglycerides

Indexed keywords

BIOLOGICAL MARKER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ANGIOCARDIOGRAPHY; ARTICLE; BLOOD; CORONARY ARTERY DISEASE; EVALUATION; FEMALE; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; RISK FACTOR;

BIOLOGICAL MARKERS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TRIGLYCERIDES;

EID: 50449085440     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322008000400003     Document Type: Article

References (20)

1. Miller NE. Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis, Am Heart J. 1987;113:589-97.
2. Robinson D, Ferns GA, Bevan EA, Stocks J, Williams PT, Galton DJ. High density lipoprotein subfractions and coronary risk factors in normal men, Arteriosclerosis. 1987;7:341-6.
3. Williams PT, Krauss RM, Vranizan KM, Stefanick ML, Wood PDS, Lindgren FT. Associations of lipoproteins and apolipoproteins with gradient gel electrophoresis estimates of high density lipoprotein subfractions in men and women, Arterioscler Thromb. 1992;12:332-40.
4. Hanak V, Munoz J, Teaque J, Stanley A Jr, Bittner V. Accuracy of the triglyceride to high-density lipoprotein cholesterol ratio for prediction of the low-density lipoprotein phenotype B, Am J Cardiol. 2004;94:219-22.
5. Da luz PL, Cesena FH, Favarato D, Cerqueira ES. Comparison of serum lipid values in patients with coronary artery disease at <50, 50 to 59, 60 to 69, and >70 years of age, Am J Cardiol. 2005;96:1640-3.
6. Rinqqvist I, Fisher LD, Mock M, Davis KB, Wedel H, Chaitman BR, et al. The Coronary Artery Surgery Study. Prognostic Value of Angiographic Indices of Coronary Artery Disease from the Coronary Artery Surgery Study (CASS), J Clin Invest. 1983;71:1854-66.
7. Krauss RM, Burke DJ. Identification of multiple subclasses of plasma low density lipoprotein in normal humans, J Lipid Res. 1982;23:97-104.
8. Scheffer PG, Bakker SJL, Heine RJ, Teerlink T. Measurement of LDL particle size in whole plasma and serum by high performance gel-filtration chromatography using a fluorescent lipid probe, Clin Chem. 1998;44:2148-51
9. Kuller L, Arnold A, Tracy R, Otvos J, Burke G, Psaty B, et al. Nuclear Magnetic Resonance Spectroscopy of Lipoproteins and Risk of Coronary Heart Disease in the Cardiovascular Health Study, Arterioscler Thromb Vasc Biol. 2002;22:1175-80.
10. Ballantyne CM, Hoogeveen RC. Role of lipid and lipotrotein profiles in risk assessment and therapy, Am Heart J. 2003;146:227-33.
11. Hong MK, Romm PA, Reagan K, Green CE, Rackley CE. Usefulness of the total cholesterol to high density lipoprotein cholesterol ratio in predicting angiographic coronary disease in women, Am J Cardiol 1991;68:1646-50.
12. Castelli WP, Anderson K, Wilson PW, Levy D. Lipids and risk of coronary heart disease. The Framingham Study, Ann Epidemiol. 1992;2:23-8.
13. Manninen V, Tenkanen L, Koshinen P, Huttunen JK, Manttari M, Heinonen PO, et al. Join effects of serum triglycerides and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Sudy. Implications for treatment, Circulation. 1992;85:37-45.
14. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;363:937-52.
15. Gotto AM Jr, Whitney E, Stein EA, Shapiro DR, Clearfield, Weis S, et al. Relation between baseline and on-treatment lipid parameters and first acute major coronary event in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/Tex CAPS), Circulation. 2000;101:477-84.
16. Walldius G, Jungner I, Holme I, Astveit AH, Kolar W, Steiner E. High apoliprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS Study): a prospective study, Lancet. 2001;358:2026-33.
17. Gaziano JM, Hennekens CH, O'Donnell CJ, Breslow JL, Buring JE. Fasting triglycerides, high density lipoprotein, and risk of myocardial infarction, Circulation. 1997; 96: 2520-5.
18. Jeppesen J, Hein HO, Suadicani P, Gyntelberg F. Triglycerides concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study, Circulation. 1998;97:1029-36.
19. Packard CJ, Shepherd J. Lipoprotein heterogenity and apolipoprotein B metabolism, Arterioscler Thromb Vasc Biol, 1999;19:2456-64.
20. Brinton EA, Eeisenberg S, Breslow JL. Increased apo A-I and apo-AII fractional catabolic rate in patients with low high density lipoprotein- cholesterol levels with or without hypertriglyceridemia, J Clin Invest. 1991;87:536-44.